Early on in the COVID-19 pandemic, the federal government implemented several telehealth flexibilities to allow states to maximize access to medications for opioid use disorder (MOUD). While these flexibilities remain allowable until the end of the federal public health emergency (PHE), state approaches to prescribing MOUD via telehealth currently vary greatly: some states explicitly allow it, some explicitly do not allow it, and some state PHEs have expired, effectively ending the practice in the absence of further guidance regarding prescribing MOUD via telehealth. This map provides a snapshot of current telehealth MOUD state policy 18 months into the COVID-19 pandemic.
This map provides a snapshot of current telehealth MOUD state policy 18 months into the COVID-19 pandemic.